1.
Long GV, Del Vecchio M, Weber J, Hoeller C, Grob J-J, Mohr P, Grabbe S, Dutriaux C, Chiarion-Sileni V, Mackiewicz J, Rutkowski P, Arenberger P, Quéreux G, Meniawy T, Ascierto PA, Durani P, Lobo M, Campigotto F, Gastman B, Kirkwood JM. Adjuvant therapy with nivolumab versus placebo in patients with resected stage IIB/C melanoma (CheckMate 76K). J of Skin [Internet]. 2023Mar.13 [cited 2024Jul.3];7(2):s163. Available from: https://jofskin.org/index.php/skin/article/view/2021